BOSTON, June 20, 2017 /PRNewswire/ -- Kyros Law Offices
is alerting investors of Valeant Pharmaceuticals Intl (NYSE:
VRX) that it is investigating legal claims against the company
for possible securities fraud violations committed by Valeant
Pharmaceuticals Intl (NYSE: VRX).
Valeant Pharmaceuticals Intl (NYSE: VRX) investors that
have invested over $100,000 before
March 2016 are urged to contact our
law firm immediately to protect their rights. Visit our VRX
Lawsuit website or call 1-800-934-2921 to speak to
someone about your case.
The investigation concerns possible violations of securities law
committed by Valeant Pharmaceuticals Intl (NYSE: VRX)
management that has led to significant losses to investors. Recent
lawsuits filed against the company allege that Valeant
Pharmaceuticals Intl (NYSE: VRX) may have improperly used a
pharmacy network to artificially increase sales for their
drugs.
In February 2016, Valeant
Pharmaceuticals Intl (NYSE: VRX) announced it would restate
its financial results, citing issues with revenue recognition
stemming from sales from a specific pharmacy network. That same
month, the company came under SEC investigation. During this time,
the stock price of VRX dropped significantly, with the share prices
dropping more than 90%.
Kyros Law Offices urges Valeant Pharmaceuticals Intl (NYSE:
VRX) investors that invested more than $100,000 prior to March
2016 to contact our law firm immediately to protect their
rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to
find out if you have a case.
Kyros Law specializes in a
wide range of complex litigation, mass torts, and corporate
governance matters, including the representation of whistleblowers,
shareholders and consumers in securities fraud, false claims act
and class actions. Our lawyers have been responsible for recovering
hundreds of millions of dollars for our clients throughout
the United States, Africa, Asia
and Europe. Visit our
website to learn more about our firm.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vrx-investor-alert-kyros-law-is-investigating-legal-claims-on-behalf-of-valeant-pharmaceuticals-intl-nyse-vrx-investors-300477099.html
SOURCE Kyros Law